Demand for cellular reprogramming tools will increase through 2036, with adult stem cells at 42.0% of the product segment in 2026. The market was valued at USD 446.8 million in 2025 and is expected to reach USD 780.3 million by 2036, creating an incremental opportunity of USD 310.3 million.